Replies to post #114355 on NanoViricides Inc. (NNVC)

[Rawnoc]

San Diego – July 27, 2015 – Ansun BioPharma, Inc., a San Diego-based biotech company, is
pleased to announce that an investigation by the United States Attorney’s office over the
misconduct of the former CEO and CFO has been dismissed

[Rawnoc]

Fludase for the Treatment of Influenza
Fludase is a new First-in-Class broad spectrum host directed influenza investigational antiviral

Fludase is active in vitro against all strains of influenza isolated tested to date including H5N1, H1N1, H7N9 and drug resistant viral strains and thus may be useful for pandemic stockpiling

U.S. Government has provided strong funding support (over $100 Million) for the development of Fludase

Ansun has completed a Pivotol Phase 2B trial in influenza